Recombinant FVIIa in children with liver disease

Thrombosis Research

Volumn 116, Issue 3, 2005, Pages 185-197

  Pettersson, Maria ^a   Fischler, Björn ^a   Petrini, Pia ^a   Schulman, Sam ^a   Nemeth, Antal ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Child; Gastrointestinal haemorrhage; Haemostasis; Liver diseases; Octreotide; Recombinant factor VIIa (rFVIIa)

Indexed keywords

FRESH FROZEN PLASMA; HEMOGLOBIN; OCTREOTIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE CONCENTRATE; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; LIVER DISEASE; LIVER HEMORRHAGE; MALE; PRIORITY JOURNAL; THROMBOSIS; TREATMENT FAILURE; TREATMENT INDICATION;

ADOLESCENT; BLOOD COMPONENT TRANSFUSION; CHILD; CHILD, PRESCHOOL; FACTOR VII; HEMOGLOBINS; HEMORRHAGE; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASES; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 20144383738     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.11.020     Document Type: Article

References (32)

1. P.V. Holland Post-transfusion hepatitis: current risks and causes Vox Sang. 74 Suppl. 2 1998 135 141
2. J.B. Heikenen, J.F. Pohl, S.L. Werlin, and J.C. Bucuvalas Octreotide in pediatric patients J. Pediatr. Gastroenterol. Nutr. 35 2002 600 609
3. D.A. Kelly Managing liver failure Postgrad. Med. J. 78 2002 660 667
4. P.C. Gotzsche Somatostatin analogues for acute bleeding oesophageal varices Cochrane Database Syst. Rev. 2002 Issue 1. Art No: [CD000193]
5. P.M. Mannucci Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years Blood 90 1997 2515 2521
6. R. de Franchis, P.G. Arcidiacono, L. Carpinelli, B. Andreoni, L. Cestari, and S. Brunati Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club Hepatology 18 1993 1102 1107
7. A.H. Sutor DDAVP is not a panacea for children with bleeding disorders Br. J. Haematol. 108 2000 217 227
8. U. Hedner, and E. Erhardtsen Potential role for rFVIIa in transfusion medicine Transfusion 42 2002 114 124
9. G. Kenet, R. Walden, A. Eldad, and U. Martinowitz Treatment of traumatic bleeding with recombinant factor VIIa Lancet 354 1999 1879
10. D.E. Bernstein, L. Jeffers, E. Erhardtsen, K.R. Reddy, S. Glazer, and P. Squiban Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study Gastroenterology 113 1997 1930 1937
11. L. Jeffers, N. Chalasani, L. Balart, N. Pyrsopoulos, and E. Erhardtsen Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy Gastroenterology 123 2002 118 126
12. H.G. Hendriks, K. Meijer, J.T. de Wolf, I.J. Klompmaker, R.J. Porte, and P.J. de Kam Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study Transplantation 71 2001 402 405
13. C. Kositchaiwat, and A. Chuansumrit Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP) Thromb. Haemost. 86 2001 1125 1126
14. V.M. Shami, S.H. Caldwell, E.E. Hespenheide, K.O. Arseneau, S.J. Bickston, and B.G. Macik Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy Liver Transplant. 9 2003 138 143
15. J.D. Tobias, K. Groeper, and J.W. Berkenbosch Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients South. Med. J. 96 2003 12 16
16. A. Chuansumrit, T. Chantarojanasiri, P. Isarangkura, S. Teeraratkul, S. Hongeng, and P. Hathirat Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation Blood Coagul. Fibrinolysis 11 Suppl. 1 2000 101 105
17. A. Chuansumrit, S. Treepongkaruna, and P. Phuapradit Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases Thromb. Haemost. 85 2001 748 749
18. P. Kalicinski, A. Kaminski, T. Drewniak, H. Ismail, M. Szymczak, and M. Markiewicz Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII Transplant. Proc. 31 1999 378 379
19. J.B. Brown, K.M. Emerick, D.L. Brown, P.F. Whitington, and E.M. Alonso Recombinant factor VIIa improves coagulopathy caused by liver failure J. Pediatr. Gastroenterol. Nutr. 37 2003 268 272
20. P.F. Whitington, and G.L. Whitington Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis Gastroenterology 95 1988 130 136
21. E.F. Mammen Coagulopathies of liver disease Clin. Lab. Med. 14 1994 769 780
22. W.F. Balistreri, J.E. Heubi, and F.J. Suchy Immaturity of the enterohepatic circulation in early life: factors predisposing to "physiologic" maldigestion and cholestasis J. Pediatr. Gastroenterol. Nutr. 2 1983 346 354
23. U. Hedner NovoSeven as a universal haemostatic agent Blood Coagul. Fibrinolysis 11 Suppl. 1 2000 107 111
24. S. He, M. Blomback, G. Jacobsson Ekman, and U. Hedner The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX J. Thromb. Haemost. 1 2003 1215 1219
25. J.G. O'Grady, G.J. Alexander, K.M. Hayllar, and R. Williams Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439 445
26. S.J. Munoz Prothrombin time in fulminant hepatic failure Gastroenterology 100 1991 1480 1481
27. A.A. Bravo, S.G. Sheth, and S. Chopra Liver biopsy N. Engl. J. Med. 344 2001 495 500
28. G.W. Shaftan, C.J. Chiu, C. Dennis, and B. Harris Fundamentals of physiologic control of arterial hemorrhage Surgery 58 1965 851 856
29. L. Riddez, D. Drobin, F. Sjostrand, C. Svensen, and R.G. Hahn Lower dose of hypertonic saline dextran reduces the risk of lethal rebleeding in uncontrolled hemorrhage Shock 17 2002 377 382
30. The European Agency for the Evaluation of Medicinal Products. Novoseven European Public Assessment Report (EPAR) (Revision 5-31/1/02). Available from: URL: http://www.eudra.org/humandocs/Humans/EPAR/Novoseven/Novoseven.htm.
31. A. Villar, S. Aronis, M. Morfini, E. Santagostino, G. Auerswald, and H.F. Thomsen Pharmacokinetics of actvated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A Haemophilia 10 2004 352 359
32. J. Cohen, R.R. Edelman, and S. Chopra Portal vein thrombosis: a review Am. J. Med. 92 1992 173 182